Research Topic: monoclonal antibodies

Characterization of the Spatiotemporal Localization of a Pan-Mucorales–Specific Antigen During Germination and Immunohistochemistry

mycolabadmin

Researchers developed a test using a special antibody (TG11) that can specifically identify dangerous mold infections (mucormycosis) in tissue samples. The antibody glows when it finds the molds at early stages of growth, even when they first start germinating. Unlike other diagnostic methods, this antibody can tell the difference between dangerous Mucorales molds and other common molds like Aspergillus, which is important for doctors to give the right treatment quickly.

Read More »

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

This research developed a special antibody test to quickly identify deadly flesh-eating fungi called Apophysomyces and Saksenaea, which cause serious skin and soft tissue infections. These fungi are difficult to identify because they don’t form spores on standard laboratory media. The new test uses a simple method combining antibody detection with a rapid lateral-flow test, similar to a COVID-19 test, making diagnosis faster and more reliable in hospitals that don’t have access to expensive equipment.

Read More »

Characterization of the Spatiotemporal Localization of a Pan-Mucorales–Specific Antigen During Germination and Immunohistochemistry

mycolabadmin

Researchers developed a new diagnostic test using a special antibody that can detect Mucorales fungi, which cause a serious infection called mucormycosis. The antibody glows to mark growing fungal threads in tissue samples, helping doctors identify the infection early and distinguish it from other mold infections like Aspergillus. This breakthrough could significantly improve patient outcomes by enabling faster diagnosis and treatment of this aggressive fungal disease.

Read More »

Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis

mycolabadmin

Researchers developed a new test to detect Aspergillus fungal infections using an antibody that recognizes a fungal component called GAG. The test worked very well in mouse studies, reliably detecting the fungus in blood and other body fluids. However, when tested with samples from infected patients, the test could not find GAG in the blood or other fluids, though it could see the fungus in lung tissue. This suggests either patients don’t produce enough GAG in their bloodstream, or something in human biology interferes with detection.

Read More »

Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device

mycolabadmin

Researchers developed and tested a new rapid test (TG11-LFD) for detecting mucormycosis, a dangerous fungal infection, using a simple device similar to a COVID rapid test. The test detects a specific protein marker released by Mucorales fungi in lung fluid samples. In testing with 62 clinical samples, the new test correctly identified about 77% of actual infections and was negative in about 76% of non-infected samples. This affordable, simple test could help doctors quickly diagnose mucormycosis and start life-saving treatment faster, especially in countries with limited laboratory resources.

Read More »

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

Researchers developed a new diagnostic tool using specially designed antibodies to quickly identify dangerous flesh-eating fungi (Apophysomyces and Saksenaea) that cause severe infections. These fungi are particularly difficult to diagnose because they don’t produce spores on standard laboratory cultures. The new test can identify these pathogens in just 24-48 hours, much faster than traditional methods, which is critical since these infections progress rapidly and require immediate treatment. This advancement is especially important for hospitals in developing countries where expensive diagnostic equipment is unavailable.

Read More »

Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis

mycolabadmin

Researchers developed a new test to detect invasive fungal infections caused by Aspergillus by targeting a molecule called galactosaminogalactan (GAG) on the fungus surface. The test worked very well in mice with the infection and showed better specificity than current methods. However, the test did not detect GAG in blood or other body fluids from human patients, suggesting that additional research is needed before it can be used clinically.

Read More »
Scroll to Top